+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

Human Vaccines - Global Strategic Business Report - Product Thumbnail Image

Human Vaccines - Global Strategic Business Report

  • Report
  • May 2026
  • 448 Pages
  • Global
From
Porcine Vaccines - Global Strategic Business Report - Product Thumbnail Image

Porcine Vaccines - Global Strategic Business Report

  • Report
  • May 2026
  • 376 Pages
  • Global
From
From
Conjugate Vaccines - Global Strategic Business Report - Product Thumbnail Image

Conjugate Vaccines - Global Strategic Business Report

  • Report
  • May 2026
  • 271 Pages
  • Global
From
Shingles Vaccines - Global Strategic Business Report - Product Thumbnail Image

Shingles Vaccines - Global Strategic Business Report

  • Report
  • May 2026
  • 269 Pages
  • Global
From
From
From
Anthrax Vaccine - Global Strategic Business Report - Product Thumbnail Image

Anthrax Vaccine - Global Strategic Business Report

  • Report
  • May 2026
  • 375 Pages
  • Global
From
Brucellosis Vaccines - Global Strategic Business Report - Product Thumbnail Image

Brucellosis Vaccines - Global Strategic Business Report

  • Report
  • May 2026
  • 276 Pages
  • Global
From
Hepatitis B Vaccines - Global Strategic Business Report - Product Thumbnail Image

Hepatitis B Vaccines - Global Strategic Business Report

  • Report
  • May 2026
  • 434 Pages
  • Global
From
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • May 2026
  • 486 Pages
  • Global
From
Microbiome Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Microbiome Therapeutics - Global Strategic Business Report

  • Report
  • May 2026
  • 148 Pages
  • Global
From
Therapeutic Vaccines - Global Strategic Business Report - Product Thumbnail Image

Therapeutic Vaccines - Global Strategic Business Report

  • Report
  • May 2026
  • 346 Pages
  • Global
From
Biological Drugs - Global Strategic Business Report - Product Thumbnail Image

Biological Drugs - Global Strategic Business Report

  • Report
  • May 2026
  • 262 Pages
  • Global
From
Vaccine Adjuvants - Global Strategic Business Report - Product Thumbnail Image

Vaccine Adjuvants - Global Strategic Business Report

  • Report
  • May 2026
  • 191 Pages
  • Global
From
From
Biologics - Global Strategic Business Report - Product Thumbnail Image

Biologics - Global Strategic Business Report

  • Report
  • May 2026
  • 495 Pages
  • Global
From
From
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more